Recurrent American cutaneous Leishmaniasis [9]

Emerging Infectious Diseases

Volumn 13, Issue 9, 2007, Pages 1436-1438

  Gangneux, Jean Pierre ^a,d   Sauzet, Sylvie ^b   Donnard, Sébastien ^b   Meyer, Nicolas ^a   Cornillet, Anne ^a   Pratlong, Francine ^c   Guiguen, Claude ^a  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b Service Medical du 11Ème Régiment d'Artillerie de Marine   (France)

^c UNIV MONTPELLIER   (France)

^d PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PENTAMIDINE ISETHIONATE;

CLINICAL ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE FREE INTERVAL; FOLLOW UP; GIEMSA STAIN; HUMAN; INCIDENCE; LEISHMANIA; LEISHMANIA TROPICA; LEISHMANIASIS RECIDIVA CUTIS; LETTER; RECURRENT DISEASE; RELAPSE; RETREATMENT; SKIN LEISHMANIASIS; SMEAR; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED STATES;

EID: 34848925866     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1309.061446     Document Type: Letter

References (10)

1. Berlin C. Leishmania recidiva cutis. Leishmanid Arch Dermatol Syphilol. 1940;41:874-86.
2. Calvopina M, Uezato H, Gomez EA, Korenaga M, Nonaka S, Hashiguchi Y. Leishmaniasis recidiva cutis due to Leishmania (Viannia) panamensis in subtropical Ecuador: isoenzymatic characterization. Int J Dermatol. 2006;45:116-20.
3. Rotureau B, Ravel C, Nacher M, Couppie P, Curtet I, Dedet JP, et al. Molecular epidemiology of Leishmania (Viannia) guyanensis in French Guiana. J Clin Microbiol. 2006;44:468-73.
4. Dedet JP, Pradinaud R, Gay F. Epidemiological aspects of human cutaneous leishmaniasis in French Guiana. Trans R Soc Trop Med Hyg. 1989;83:616-20.
5. Oliveira-Neto MP, Mattos M, Souza CS, Fernandes O, Pirmez C. Leishmaniasis recidiva cutis in New World cutaneous leishmaniasis. Int J Dermatol. 1998;37:846-9.
6. Cannavo SP, Vaccaro M, Guarneri F. Leishmaniasis recidiva cutis. Int J Dermatol. 2000;39:205-6.
7. Lightburn E, Morand JJ, Meynard JB, Kraemer P, Chaudier B, Pages F, et al. Management of American cutaneous leishmaniasis: outcome of high-dose pentamidine isethionate treatment of 326 cases. Med Trop (Mars). 2003;63:35-44.
8. Roussel M, Nacher M, Fremont G, Rotureau B, Clyti E, Sainte-Marie D, et al. Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana. Ann Trop Med Parasitol. 2006;100:307-14.
9. Mendonça MG, de Brito ME, Rodrigues EH, Bandeira V, Jardim ML, Abath FG. Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure? J Infect Dis. 2004;189:1018-23.
10. Marovich MA, Lira R, Shepard M, Fuchs GH, Kreutzer R, Nutman TB, et al. Leishmaniasis recidivans recurrence after 43 years: a clinical and immunologic report after successful treatment. Clin Infect Dis. 2001;33:1076-9.